Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial
| Image |  |
|---|---|
| Description | scientific article published in September 2002 |
| Author/s |
author: Waun Ki Hong Roy S. Herbst Josep Baselga |
| Publication date | September 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |